Dr. Eugen Leo is a seasoned oncologist and immunotherapy expert, currently serving as the Chief Medical Officer at CatalYm, a German biopharmaceutical company developing novel cancer immunotherapies. With over two decades of experience in the development of targeted therapies, Dr. Leo has played pivotal roles in advancing treatments such as kinase inhibitors, monoclonal antibodies, vaccines, and cell therapies.